This document is intended as a supplement to the EANM "Guidelines on current Good Radiopharmacy Practice (cGRPP)" issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale "in-house" preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.
|Number of pages||12|
|Journal||European Journal of Nuclear Medicine and Molecular Imaging|
|Early online date||7-Apr-2022|
|Publication status||Published - Aug-2022|
- Risk assessment
- Quality assurance